New results on a possible COVID-19 vaccine from Oxford University and AstraZeneca suggest it is safe and about 70% effective, but questions remain about how well it may help protect those over 55 — a key concern for a vaccine that health officials hope to rely on around the world...
3rd Major COVID-19 Vaccine Shown to Be Effective and Cheaper
LONDON — Pharmaceutical company AstraZeneca said Monday that late-stage trials showed its coronavirus vaccine was up to 90% effective, giving public health officials hope they may soon have access to a vaccine that is cheaper and easier to distribute than some of its rivals. The results are based on interim...
Astrazeneca Says COVID-19 Vaccine Could Arrive in January of Next Year
[aggregation-styles] CBS News A long-awaited coronavirus vaccine could be available in roughly two months, according to drugmaker AstraZeneca, which is developing a treatment. The Anglo-Swedish drugmaker is working with the University of Oxford to develop one of the most closely watched COVID-19 vaccines, which is in late stage trials in...
Major COVID-19 Vaccine Study Paused After Illness
Late-stage studies of AstraZeneca's COVID-19 vaccine candidate are on temporary hold while the company investigates if a report of a patient with a serious side effect is linked to the shot. In a statement issued Tuesday evening, the company said its “standard review process triggered a pause to vaccination to...
Can Oxford University Deliver COVID Vaccine for High Risk Groups by October?
No early safety concerns. Strong immune responses in both parts of the immune system. Those are the results from Oxford University's Jenner Institute the world has been waiting for regarding a potential COVID-19 vaccine. The most optimistic timeline is that the vaccine could be available on an emergency basis for...